<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02669628</url>
  </required_header>
  <id_info>
    <org_study_id>PR314/15</org_study_id>
    <nct_id>NCT02669628</nct_id>
  </id_info>
  <brief_title>Antimullerian Hormone in Endometriomas</brief_title>
  <official_title>Anti-mullerian Hormone in Ovarian Reserve Evaluation After Treatment of Endometriomas With Alcohol Sclerotherapy Versus Surgery. A Pilot Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitari de Bellvitge</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Roche Diagnostic Ltd.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Universitari de Bellvitge</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this multicenter study is to evaluate the ovarian reserve after alcohol
      sclerotherapy of endometriomas versus conventional surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Between 5-10% fertile women are affected by endometriosis, and ovarian endometrioma is
      present in 17-44% of cases, with 40% of patients with endometriomas being sterile. However,
      the &quot;gold standard&quot; treatment is laparoscopic ovarian cystectomy and this therapy is
      associated with a diminished ovarian reserve, with a significant antimullerian hormone (AMH)
      decrease.

      Alcohol sclerotherapy is a new minimal invasive procedure in endometrioma treatment whose
      potential beneficial effect in fertility preservation is not still demonstrated.

      The investigators would like to demonstrate that this procedure improves fertility
      preservation and reduces morbidity and costs in contrast with conventional surgery.
      Moreover,the investigators would like to demonstrate that this procedure could be performed
      in different centers with similar results.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2016</start_date>
  <completion_date type="Actual">January 2018</completion_date>
  <primary_completion_date type="Actual">January 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>AMH Test</measure>
    <time_frame>6 months</time_frame>
    <description>the value of AMH after both procedures in ng/mL</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>antral follicles count</measure>
    <time_frame>6 months</time_frame>
    <description>US antral follicles count after both procedures</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>tumoral markers: epididimal human protein 4 (HE-4) and CA125</measure>
    <time_frame>6 months</time_frame>
    <description>the value tumoral markers after both procedures</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>complications</measure>
    <time_frame>1 day</time_frame>
    <description>number of participants with complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>costs</measure>
    <time_frame>1 day</time_frame>
    <description>costs (euros) of the procedures and their complications</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">34</enrollment>
  <condition>Endometriomas</condition>
  <arm_group>
    <arm_group_label>Surgical technique</arm_group_label>
    <description>Laparoscopic ovarian cystectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Alcohol sclerotherapy</arm_group_label>
    <description>US-aspiration and alcohol sclerosis</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Surgical technique</intervention_name>
    <description>Laparoscopic surgery</description>
    <arm_group_label>Surgical technique</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Alcohol sclerotherapy</intervention_name>
    <description>US-guided sclerotherapy</description>
    <arm_group_label>Alcohol sclerotherapy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with ultrasound suspicion of ovarian endometrioma (4-10 cm)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women

          -  Age ≥18 and &lt;40 years

          -  Unilocular endometrioma according ultrasounds

          -  Endometrioma size: 35-100 mm during &gt; 3 months from diagnosis

          -  CA125 &lt;200 IU/mL and HE4 &lt; 70,

          -  AMH previous surgery between 1.2-4 ng/mL

        Exclusion Criteria:

          -  Previous ovarian surgery or gynecological cancer

          -  Severe extraovarian endometriosis

          -  Dermoid or high risk of malignancy cysts

          -  Hormonal treatment 3 months before

          -  Pregnancy

          -  Mental disability
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amparo Garcia-Tejedor, MDPhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital de Bellvitge. IDIBELL</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Universitario Bellvitge</name>
      <address>
        <city>Hospitalet de Llobregat</city>
        <state>Barcelona</state>
        <zip>08908</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Coccia ME, Rizzello F, Cammilli F, Bracco GL, Scarselli G. Endometriosis and infertility Surgery and ART: An integrated approach for successful management. Eur J Obstet Gynecol Reprod Biol. 2008 May;138(1):54-9. doi: 10.1016/j.ejogrb.2007.11.010. Epub 2008 Feb 20.</citation>
    <PMID>18243485</PMID>
  </reference>
  <reference>
    <citation>Muzii L, Bianchi A, Crocè C, Manci N, Panici PB. Laparoscopic excision of ovarian cysts: is the stripping technique a tissue-sparing procedure? Fertil Steril. 2002 Mar;77(3):609-14.</citation>
    <PMID>11872220</PMID>
  </reference>
  <reference>
    <citation>Raffi F, Metwally M, Amer S. The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2012 Sep;97(9):3146-54. doi: 10.1210/jc.2012-1558. Epub 2012 Jun 20. Review.</citation>
    <PMID>22723324</PMID>
  </reference>
  <reference>
    <citation>Biacchiardi CP, Piane LD, Camanni M, Deltetto F, Delpiano EM, Marchino GL, Gennarelli G, Revelli A. Laparoscopic stripping of endometriomas negatively affects ovarian follicular reserve even if performed by experienced surgeons. Reprod Biomed Online. 2011 Dec;23(6):740-6. doi: 10.1016/j.rbmo.2011.07.014. Epub 2011 Jul 27.</citation>
    <PMID>22019621</PMID>
  </reference>
  <reference>
    <citation>Akamatsu N, Hirai T, Masaoka H, Sekiba K, Fujita T. [Ultrasonically guided puncture of endometrial cysts--aspiration of contents and infusion of ethanol]. Nihon Sanka Fujinka Gakkai Zasshi. 1988 Feb;40(2):187-91. Japanese.</citation>
    <PMID>3283269</PMID>
  </reference>
  <reference>
    <citation>Noma J, Yoshida N. Efficacy of ethanol sclerotherapy for ovarian endometriomas. Int J Gynaecol Obstet. 2001 Jan;72(1):35-9.</citation>
    <PMID>11146075</PMID>
  </reference>
  <reference>
    <citation>Messalli EM, Cobellis G, Pecori E, Pierno G, Scaffa C, Stradella L, Cobellis L. Alcohol sclerosis of endometriomas after ultrasound-guided aspiration. Minerva Ginecol. 2003 Aug;55(4):359-62.</citation>
    <PMID>14581861</PMID>
  </reference>
  <reference>
    <citation>Kafali H, Eser A, Duvan CI, Keskin E, Onaran YA. Recurrence of ovarian cyst after sclerotherapy. Minerva Ginecol. 2011 Feb;63(1):19-24.</citation>
    <PMID>21311417</PMID>
  </reference>
  <reference>
    <citation>Yazbeck C, Madelenat P, Ayel JP, Jacquesson L, Bontoux LM, Solal P, Hazout A. Ethanol sclerotherapy: a treatment option for ovarian endometriomas before ovarian stimulation. Reprod Biomed Online. 2009 Jul;19(1):121-5.</citation>
    <PMID>19573300</PMID>
  </reference>
  <reference>
    <citation>García-Tejedor A, Castellarnau M, Ponce J, Fernández ME, Burdio F. Ethanol sclerotherapy of ovarian endometrioma: a safe and effective minimal invasive procedure. Preliminary results. Eur J Obstet Gynecol Reprod Biol. 2015 Apr;187:25-9. doi: 10.1016/j.ejogrb.2015.02.004. Epub 2015 Feb 16.</citation>
    <PMID>25739052</PMID>
  </reference>
  <reference>
    <citation>Somigliana E, Berlanda N, Benaglia L, Viganò P, Vercellini P, Fedele L. Surgical excision of endometriomas and ovarian reserve: a systematic review on serum antimüllerian hormone level modifications. Fertil Steril. 2012 Dec;98(6):1531-8. doi: 10.1016/j.fertnstert.2012.08.009. Epub 2012 Sep 10. Review.</citation>
    <PMID>22975114</PMID>
  </reference>
  <reference>
    <citation>Koike T, Minakami H, Motoyama M, Ogawa S, Fujiwara H, Sato I. Reproductive performance after ultrasound-guided transvaginal ethanol sclerotherapy for ovarian endometriotic cysts. Eur J Obstet Gynecol Reprod Biol. 2002 Oct 10;105(1):39.</citation>
    <PMID>12270563</PMID>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 23, 2016</study_first_submitted>
  <study_first_submitted_qc>January 27, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 1, 2016</study_first_posted>
  <last_update_submitted>February 21, 2018</last_update_submitted>
  <last_update_submitted_qc>February 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Universitari de Bellvitge</investigator_affiliation>
    <investigator_full_name>Amparo Garcia-Tejedor</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endometriosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hormones</mesh_term>
    <mesh_term>Ethanol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The individual participant data should be available 6 months after the procedure</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

